Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
Ayelet Grupper, Liane Rabinowich, Doron Schwartz, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2719-2726
Open Access | Times Cited: 357

Showing 1-25 of 357 citing articles:

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Victoria Furer, Tali Eviatar, Devy Zisman, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1330-1338
Open Access | Times Cited: 606
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
Tal Brosh‐Nissimov, Efrat Orenbuch‐Harroch, Michal Chowers, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1652-1657
Open Access | Times Cited: 337
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine
Julian Stumpf, Torsten Siepmann, Tom H. Lindner, et al.
The Lancet Regional Health - Europe (2021) Vol. 9, pp. 100178-100178
Open Access | Times Cited: 286
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
David Cucchiari, Natalia Egri, Marta Bodro, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2727-2739
Open Access | Times Cited: 226
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp, et al.
Transplantation (2021) Vol. 106, Iss. 4, pp. 821-834
Open Access | Times Cited: 161
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
Clément Danthu, Sébastien Hantz, Arthur Dahlem, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 9, pp. 2153-2158
Open Access | Times Cited: 160
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients
Caroline X. Qin, Linda W. Moore, Shweta Anjan, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e265-e266
Open Access | Times Cited: 155
Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants
Olivier Marion, Arnaud Del Bello, Florence Abravanel, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 9, pp. 1336-1338
Open Access | Times Cited: 146
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
Victoria Hall, Victor H. Ferreira, Matthew Ierullo, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3980-3989
Open Access | Times Cited: 143
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
Tina Schmidt, Verena Klemis, David Schub, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3990-4002
Open Access | Times Cited: 142
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
José Jesús Broseta, Diana Rodríguez‐Espinosa, Néstor Rodríguez, et al.
American Journal of Kidney Diseases (2021) Vol. 78, Iss. 4, pp. 571-581
Open Access | Times Cited: 112
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 111
The RECOVAC Immune-response Study
Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp, et al.
(2021) Vol. Publish Ahead of Print
Open Access | Times Cited: 108
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD
Edward J Carr, Andreas Kronbichler, Matthew Graham‐Brown, et al.
Kidney International Reports (2021) Vol. 6, Iss. 9, pp. 2292-2304
Open Access | Times Cited: 107
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review
Kin Israel Notarte, Abbygail Therese Ver, Jacqueline Veronica Velasco, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 6, pp. 373-390
Open Access | Times Cited: 88
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
Ghady Haidar, Mounzer Agha, Andrew Bilderback, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e630-e644
Open Access | Times Cited: 81
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 76
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
Daniel Lozano‐Ojalvo, Carmen Cámara, Eduardo López‐Granados, et al.
Cell Reports (2021) Vol. 36, Iss. 8, pp. 109570-109570
Open Access | Times Cited: 99
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot, Antoine Morel, Marianne Leruez‐Ville, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 4043-4051
Open Access | Times Cited: 93
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
Mark A. Brockman, Francis Mwimanzi, Hope R. Lapointe, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 7, pp. 1129-1140
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top